Pancreatic Cancer Research

ResearcherMayo ClinicNo recent work listed

Julian R. Molina

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9962-4635; OpenAlex author ID A5038755935. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

  1. Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer. Co-author DOI 10.1016/j.pan.2019.11.011↗
  2. Phase I dose escalation study of the PKCι inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer. Last author DOI 10.1097/cad.0000000000000009↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Aminah Jatoi · 2 shared papers, 2013–2020 · strength 0.12
  2. Charles Erlichman · 2 shared papers, 2013–2020 · strength 0.12
  3. Wilma Lingle · 1 shared paper, 2020 · strength 0.08
  4. Mitesh J. Borad · 1 shared paper, 2020 · strength 0.08
  5. Thomas C. Smyrk · 1 shared paper, 2020 · strength 0.08
  6. Ezequiel J. Tolosa · 1 shared paper, 2020 · strength 0.08
  7. Angela L. McCleary‐Wheeler · 1 shared paper, 2020 · strength 0.08
  8. Axel F. Grothey · 1 shared paper, 2020 · strength 0.08
  9. Ryan Michael Carr · 1 shared paper, 2020 · strength 0.08
  10. Henry Clement Pitot · 1 shared paper, 2020 · strength 0.08
  11. George P. Kim · 1 shared paper, 2020 · strength 0.08
  12. Mien‐Chie Hung · 1 shared paper, 2020 · strength 0.08
  13. Tanios Bekaii‐Saab · 1 shared paper, 2020 · strength 0.08
  14. Robert R. McWilliams · 1 shared paper, 2020 · strength 0.08
  15. Martín E. Fernández-Zapico · 1 shared paper, 2020 · strength 0.08
  16. Alex A. Adjei · 1 shared paper, 2013 · strength 0.04
  17. Aaron Scott Mansfield · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.